Aspire Biopharma Holdings, Inc. (ASBP)
0.1045
+0.02
(+22.51%)
USD |
NASDAQ |
Dec 11, 16:00
0.102
0.00 (0.00%)
Pre-Market: 08:11
Aspire Biopharma Holdings EPS Diluted (Quarterly): -0.0374 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Salarius Pharmaceuticals, Inc. | -1.814 |
| Taysha Gene Therapies, Inc. | -0.0926 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Invivyd, Inc. | -0.0615 |
| MSP Recovery, Inc. | -132.71 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.850M |
| Revenue (Quarterly) | 0.0019M |
| Total Expenses (Quarterly) | 1.852M |
| Enterprise Value | 17.91M |
| Gross Profit Margin (Quarterly) | 47.37% |
| Profit Margin (Quarterly) | -97.39K% |
| Earnings Yield | -1.58K% |
| Normalized Earnings Yield | -826.32 |